Seegene, Inc.
Myungji Building, 142-21 Samsung-dong
Kangnam-gu
Seoul
135-090
Tel: 82-2-566-9830
Fax: 82-2-566-9831
Website: http://www.see-gene.com/
Email: info@see-gene.com
137 articles about Seegene, Inc.
-
Seegene, Inc. and DuPont Nutrition & Health Agree to Develop Highly Multiplexed Molecular Assays for Food Safety Testing
5/24/2012
-
Seegene, Inc. Strengthens Position in Multiplex PCR With Award of United States Patent for Dual Priming Oligonucleotide (DPO(TM)) Technology
1/17/2012
-
Seegene, Inc. Introduces Anyplex(TM) II RV16 Detection Assay Ahead of Seasonal Onset for Influenza and Viral Epidemics
10/24/2011
-
Seegene, Inc. Awarded European Patent for Dual Priming Oligonucleotide (DPO(TM)) Technology
10/21/2011
-
Seegene, Inc. Introduces Anyplex(TM)II STI-7 Detection Assay
9/20/2011
-
Study Finds Seegene, Inc. Seeplex(R) DV Multiplex Test Reliably Detects Diarrheal Pathogens More Effectively and Economically Than 'Home Brew' Tests
8/15/2011
-
Seegene, Inc. Introduces Anyplex(TM)plus MTB/NTM/DR-TB Real-time Test, a One-Stop Solution for Diagnosing Tuberculosis
7/25/2011
-
Seegene, Inc. Announces a New Concept of Real-Time Multiplex Diagnostic Technology
7/20/2011
-
Akonni Biosystems and Seegene, Inc. Enter Into Licensing Agreement
5/9/2011
-
Seegene, Inc. and Samsung Medical Center Enter Co-Development Deal to Develop Molecular Diagnostics for Cancer
4/7/2011
-
Seegene, Inc. Announces Magicplex(TM) RV Panel Real-Time Test
11/1/2010
-
Biosearch Technologies and Seegene, Inc. Finalize Oligonucleotide Supply and BHQ(R), CAL Fluor(R) and Quasar(R) Licensing Agreements
10/20/2010
-
Seegene, Inc. Raises USD 16.6 Million in Initial Public Offering on KOSDAQ
9/13/2010
-
Seegene, Inc. Announce SeePrep(TM) and SeeCycler(TM) to Create Complete Molecular Diagnostic System
7/26/2010
-
Seegene, Inc. Introduces First Real-time Molecular Diagnostic Test for Tuberculosis and Multi-drug Resistant Tuberculosis
7/22/2010
-
Seegene, Inc.'s New Magicplex(TM) Sepsis Test Indentifies Over 90 Indicators for Deadly In-Hospital Disease
7/20/2010
-
A New Pediatric Study Finds Seegene, Inc.'s Seeplex(R) Assay to Be 'Excellent' as a Diagnostic Test for Detecting Respiratory Viruses
5/26/2010
-
Seegene, Inc. READ PCR Study Finds High Rate of False Negatives Among Current Tests for Tuberculosis and Sexually Transmitted Disease
4/9/2010
-
Seegene, Inc. Breaks Barriers of Conventional PCR and Real-Time PCR Techniques With Powerful New Platform for New Molecular Diagnostic Tests
3/15/2010
-
Seegene, Inc. Seeplex(R) Diarrhea-V ACE Detection Test Receives a Medical Device License From Health Canada
1/11/2010